CROSS-REFERENCE TO RELATED APPLICATIONS
The present application is a National Phase of International Application No. PCT/EP2014/064743, filed on Jul. 9, 2014, which claims priority to Sweden Patent Application No. 1350879-1, filed Jul. 15, 2013, the entire contents of each of which are incorporated
FIELD OF INVENTION
The present invention generally relates to hemodialysis and similar dialysis systems, e.g., systems able to treat blood or other bodily fluids extracorporeally. In certain aspects, the systems include a variety of systems and methods that would make hemodialysis more efficient,
BACKGROUND OF THE INVENTION
The invention is concerned with a peritoneal dialysis device with a balancing arrangement with two chambers, each of which can be switched with a valve arrangement into a filling or emptying phase, with the peritoneal dialysis liquid source connected to the balancing
The present application is a .sctn. 371submission of international application no. PCT/GB2012/000113, which was filed on 2 Feb. 2012 and entitled Dialysis Machine, and which was published in the English language on 8 Aug. 2013 with publication no. WO 2013/114063 A1.
The present invention relates to
FIELD OF THE INVENTION
The present invention relates to a method for monitoring a dosage pump intended for pumping a concentrate to be diluted in water. More particularly, the present invention relates to a monitoring system for a dosage pump for pumping a concentrate fluid at a very low flow rate,
FIELD OF THE INVENTION
The present invention relates generally to compositions and methods for the treatment of cardiovascular disease. More particularly, the present invention relates to modifying thrombus formation and growth by administering a heparin cofactor II-specific (HCII) catalytic agent
FIELD OF THE INVENTION
The present invention relates generally to compositions and methods for the treatment of cardiovascular disease. More particularly, the present invention relates to modifying thrombus formation and growth by administering an agent capable of selectively inactivating thrombin
FIELD OF THE INVENTION
The present invention relates generally to compositions and methods for the treatment of cardiovascular disease. More particularly, the present invention relates to modifying thrombus formation and growth by administering an agent which, inter alia, is capable of (1)
FIELD OF THE INVENTION
The present invention relates to high cut-off hemodialysis membranes for the treatment of chronic hemodialysis (CHD) patients, with the potential to improve long-term survival of these patients by reducing the risk of cardiovascular disease, through down-regulation of monocyte
FIELD OF INVENTION
The present invention relates to a method and a device for controlling an extracorporeal blood treatment apparatus, which can be operated in particular as a hemodialysis apparatus, a hemofiltration apparatus or a hemodiafiltration apparatus. Moreover, the present invention relates
FIELD OF THE INVENTION
The present invention relates to methods for reducing iron levels in mammals. In a particular aspect, the present invention relates to methods for reducing free iron ion levels in mammals by administration of dithiocarbamates as scavengers of free iron ions in hosts undergoing
FIELD OF THE INVENTION
This invention relates generally to novel entrapment of nitric oxide-releasing metal compounds, whether salts or complexes into drug delivery systems and methods for using them, more particularly for the prevention of restenosis after percutaneous transluminal coronary
FIELD OF THE INVENTION
The present invention relates generally to processes for the preparation of low affinity, low molecular weight heparins (LA-LMW-heparins) which are useful, inter alia, as antithrombotics. More particularly, the present invention relates to processes for the preparation of
FIELD OF THE INVENTION
The present invention relates generally to compositions and methods for the treatment of cardiovascular disease. More particularly, the present invention relates to modifying thrombus formation and growth by administering a modified low molecular weight heparin (MLMWH) that,
Den mest komplette databasen med medisinske urter støttet av vitenskap
Fungerer på 55 språk
Urtekurer støttet av vitenskap
Urtegjenkjenning etter bilde
Interaktivt GPS-kart - merk urter på stedet (kommer snart)
Les vitenskapelige publikasjoner relatert til søket ditt
Søk medisinske urter etter deres effekter
Organiser dine interesser og hold deg oppdatert med nyheter, kliniske studier og patenter
Skriv inn et symptom eller en sykdom og les om urter som kan hjelpe, skriv en urt og se sykdommer og symptomer den brukes mot. * All informasjon er basert på publisert vitenskapelig forskning